Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 678

    1.

    Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.

    Gould MK, Sanders GD, Barnett PG, Rydzak CE, Maclean CC, McClellan MB, Owens DK.

    Ann Intern Med. 2003 May 6;138(9):724-35.PMID: 12729427 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.

    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.

    Eur J Nucl Med. 2000 Oct;27(10):1441-56.PMID: 11083532 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease.

    Garber AM, Solomon NA.

    Ann Intern Med. 1999 May 4;130(9):719-28.PMID: 10357690 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Analysis models to assess cost effectiveness of the four strategies for the work-up of solitary pulmonary nodules.

    Tsushima Y, Endo K.

    Med Sci Monit. 2004 May;10(5):MT65-72. Epub 2004 Apr 28.PMID: 15114278 [PubMed - indexed for MEDLINE]Related articles

    6.

    Solitary pulmonary nodules: impact of quantitative contrast-enhanced CT on the cost-effectiveness of FDG-PET.

    Comber LA, Keith CJ, Griffiths M, Miles KA.

    Clin Radiol. 2003 Sep;58(9):706-11.PMID: 12943643 [PubMed - indexed for MEDLINE]Related articles

    7.

    Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.

    Klose T, Leidl R, Buchmann I, Brambs HJ, Reske SN.

    Eur J Nucl Med. 2000 Oct;27(10):1457-64.PMID: 11083533 [PubMed - indexed for MEDLINE]Related articles

    8.

    Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.

    Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton A, Thomas S, Locker T, Ryan A.

    Health Technol Assess. 2006 May;10(15):1-168, iii-iv. Review.PMID: 16707072 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Solitary pulmonary nodules: accuracy and cost-effectiveness of sodium iodide FDG-PET using Australian data.

    Keith CJ, Miles KA, Griffiths MR, Wong D, Pitman AG, Hicks RJ.

    Eur J Nucl Med Mol Imaging. 2002 Aug;29(8):1016-23. Epub 2002 May 25.PMID: 12173015 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Cost-effectiveness of PET in the management algorithms of lung tumors: comparison of health economic data]

    Dietlein M, Moka D, Weber K, Theissen P, Schicha H.

    Nuklearmedizin. 2001 Aug;40(4):122-8. German. PMID: 11556202 [PubMed - indexed for MEDLINE]Related articles

    11.

    Children with suspected craniosynostosis: a cost-effectiveness analysis of diagnostic strategies.

    Medina LS, Richardson RR, Crone K.

    AJR Am J Roentgenol. 2002 Jul;179(1):215-21.PMID: 12076939 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Management strategies for the solitary pulmonary nodule.

    Ost D, Fein A.

    Curr Opin Pulm Med. 2004 Jul;10(4):272-8. Review.PMID: 15220751 [PubMed - indexed for MEDLINE]Related articles

    13.

    Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.

    Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H.

    Eur J Nucl Med. 2000 Nov;27(11):1598-609.PMID: 11105815 [PubMed - indexed for MEDLINE]Related articles

    14.

    Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.

    Lejeune C, Al Zahouri K, Woronoff-Lemsi MC, Arveux P, Bernard A, Binquet C, Guillemin F.

    Eur J Health Econ. 2005 Sep;6(3):203-14.PMID: 15834623 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis.

    Scott WJ, Shepherd J, Gambhir SS.

    Ann Thorac Surg. 1998 Dec;66(6):1876-83; discussion 1883-5.PMID: 9930463 [PubMed - indexed for MEDLINE]Related articles

    16.

    The cost-effectiveness of fluorodeoxyglucose 18-F positron emission tomography in the N0 neck.

    Hollenbeak CS, Lowe VJ, Stack BC Jr.

    Cancer. 2001 Nov 1;92(9):2341-8.PMID: 11745289 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Cost-effectiveness of diagnostic strategies for patients with chest pain.

    Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS.

    Ann Intern Med. 1999 May 4;130(9):709-18.PMID: 10357689 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Economic analyses on the use of positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy.

    Gugiatti A, Grimaldi A, Rossetti C, Lucignani G, De Marchis D, Borgonovi E, Fazio F.

    Q J Nucl Med Mol Imaging. 2004 Mar;48(1):49-61.PMID: 15195004 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.

    Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP.

    Chest. 1993 Oct;104(4):997-1002.PMID: 8404239 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?

    Hayashi K, Abe K, Yano F, Watanabe S, Iwasaki Y, Kosuda S.

    Ann Nucl Med. 2005 Jul;19(5):393-8.PMID: 16164196 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data